Limited role of multi-attribute utility scale and SF-36 in predicting management outcome of heavy menstrual bleeding

2010 ◽  
Vol 148 (1) ◽  
pp. 81-85 ◽  
Author(s):  
Marwan Habiba ◽  
Sophia Julian ◽  
Nicholas Taub ◽  
Michael Clark ◽  
Aly Rashid ◽  
...  
Keyword(s):  
Heavy Menstrual Bleeding ◽  
Menstrual Bleeding ◽  
Limited Role ◽  
Sf 36 ◽  
Utility Scale

scholarly journals The prevalence and impacts heavy menstrual bleeding on anemia, fatigue and quality of life in women of reproductive age

2019 ◽  
Vol 35 (2) ◽  
Author(s):  
Semra Kocaoz ◽  
Rabiye Cirpan ◽  
Arife Zuhal Degirmencioglu
Keyword(s):  
Quality Of Life ◽  
Ferritin Level ◽  
Reproductive Age ◽  
Heavy Menstrual Bleeding ◽  
Menstrual Bleeding ◽  
Women Of Reproductive Age ◽  
Creative Commons ◽  
Sf 36 ◽  
Quality Of Life Scale

Objectives: To investigate the prevalence and impacts of heavy menstrual bleeding (HMB) on anemia, fatigue, and the quality of life (QoL) in women of reproductive age. Methods: This study was conducted among 306 women of reproductive age who presented at the internal medicine outpatient departments of the training and research hospital of a university. The data of the study were collected by the “Data collection form”, “SF-36 Quality of Life Scale (SF-36 QoLS)” and “Brief Fatigue Inventory (BFI)”. Results: The prevalence of HMB in women of reproductive age was 37.9%. The ferritin level and physical functions were found to decrease significantly as the duration of menstruation increased (p<0.05). Besides, a positive but very weak relationship was found between the menstruation duration and the subdimensions of the global BFI and the general health perception subscale of the SF-36 QoLS (p<0.05). Conclusion: It was determined that HMB is common and has negative effects on anemia, fatigue and some subdimensions of the QoL. Regular screening for HMB that may not be expressed by many women may therefore be useful in preventing and resolving the health problems that it will cause. How to cite this:Kocaoz S, Cirpan R, Degirmencioglu AZ. The prevalence and impacts heavy menstrual bleeding on anemia, fatigue and quality of life in women of reproductive age. Pak J Med Sci. 2019;35(2):---------. doi: https://doi.org/10.12669/pjms.35.2.644 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

scholarly journals Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist

Blood ◽  
2018 ◽  
Vol 132 (20) ◽  
pp. 2134-2142 ◽  
Author(s):  
Sarah H. O’Brien
Keyword(s):  
Iron Deficiency ◽  
Bleeding Disorder ◽  
Heavy Menstrual Bleeding ◽  
Menstrual Bleeding ◽  
Laboratory Evaluation ◽  
Hormonal Contraceptives ◽  
First Line Therapy ◽  
Sanitary Products ◽  
Menstrual History

Abstract Heavy menstrual bleeding (HMB) is frequently reported by adolescents. The role of the hematologist is threefold in evaluating such patients: (1) perform a clinical and laboratory evaluation for an underlying bleeding disorder on the basis of the degree of clinical suspicion, (2) identify and manage any concomitant iron deficiency, and (3) provide input to the referring provider regarding the management of HMB, particularly for patients with identified hemostatic defects. Several clues in the menstrual history should raise suspicion for an underlying bleeding disorder, such as menses lasting &gt;7 days, menstrual flow which soaks &gt;5 sanitary products per day or requires product change during the night, passage of large blood clots, or failure to respond to conventional therapies. A detailed personal and family history of other bleeding symptoms should also be obtained. Iron deficiency with and without anemia is commonly found in young women with HMB. Therefore, it is important to obtain measures of hemoglobin and ferritin levels when evaluating these patients. Iron supplementation is often a key component of management in the adolescent with heavy menses and is still needed in those who have received packed red cell transfusions as a result of severe anemia. Strategies for decreasing menstrual blood flow are similar for adults and adolescents with heavy menses, with combined hormonal contraceptives recommended as first-line therapy. However, there are adolescent-specific considerations for many of these agents, and they must be incorporated into shared decision-making when selecting the most appropriate treatment.

scholarly journals Role of Serum HIF-1alpha and VEGF-A as an Angiogenic Factors in Women with Heavy Menstrual Bleeding

2016 ◽  
Vol 9 (37) ◽  
Author(s):  
Yousef Rezaei Chianeh ◽  
Ullas Kamath ◽  
Azadeh Bagheri ◽  
Lavanya Rai ◽  
Pratap Kumar ◽  
...  
Keyword(s):  
Angiogenic Factors ◽  
Heavy Menstrual Bleeding ◽  
Menstrual Bleeding

scholarly journals Role of LNG-IUS in adenomyosis in reproductive age group women: a prospective interventional study

2019 ◽  
Vol 8 (4) ◽  
pp. 1254
Author(s):  
Eshna Gupta ◽  
Shashi Prateek ◽  
Poonam Mani ◽  
Lalita Yadav ◽  
Mamta Tyagi ◽  
...  
Keyword(s):  
Blood Loss ◽  
Assessment Tool ◽  
Subjective Assessment ◽  
Reproductive Age ◽  
Heavy Menstrual Bleeding ◽  
Menstrual Bleeding ◽  
Common Side Effect ◽  
Loss Assessment

Background: The objective of the present study was to observe the efficacy of LNG-IUS in the treatment of heavy menstrual bleeding and dysmenorrhoea associated with adenomyosis.Methods: LNG-IUS was inserted in forty women between 20-50 years of age presenting with heavy menstrual bleeding and dysmenorrhoea associated with adenomyosis diagnosed on transvaginal ultrasonography and followed up after 1 month, 3 months and 6 months of insertion. Subjective assessment of menstrual blood loss was done by pictorial blood loss assessment chart and dysmenorrhoea was assessed on the basis of universal pain assessment tool and side effects were noted at each visit.Results: Mean patients’ age was between 31-40 years (72.5%) and the follow up duration was 6 months. Significant improvements in dysmenorrhea, HMB and haemoglobin levels were observed. There was no significant change in the uterine volume. The most common side effect was prolonged vaginal spotting (n=26, 65%) and pain abdomen (n=13, 32.5%). LNG-IUS expulsion was observed in 1 patient (n=1, 2.5%). 3 patients underwent hysterectomy (n=3, 7.5%). The overall success rate of LNG-IUS was 82.5%.Conclusions: The LNG-IUS appears to be an effective method in alleviating dysmenorrhoea and heavy menstrual bleeding associated with adenomyosis during 6 months of study. It may be a valuable long-term alternative for the treatment of adenomyosis in young and perimenopausal women and it is a good strategy to reduce the number of hysterectomies in women with adenomyosis.

scholarly journals Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist

Hematology ◽  
2018 ◽  
Vol 2018 (1) ◽  
pp. 390-398 ◽  
Author(s):  
Sarah H. O’Brien
Keyword(s):  
Iron Deficiency ◽  
Bleeding Disorder ◽  
Heavy Menstrual Bleeding ◽  
Menstrual Bleeding ◽  
Laboratory Evaluation ◽  
Hormonal Contraceptives ◽  
First Line Therapy ◽  
Sanitary Products ◽  
Menstrual History

Abstract Heavy menstrual bleeding (HMB) is frequently reported by adolescents. The role of the hematologist is threefold in evaluating such patients: (1) perform a clinical and laboratory evaluation for an underlying bleeding disorder on the basis of the degree of clinical suspicion, (2) identify and manage any concomitant iron deficiency, and (3) provide input to the referring provider regarding the management of HMB, particularly for patients with identified hemostatic defects. Several clues in the menstrual history should raise suspicion for an underlying bleeding disorder, such as menses lasting >7 days, menstrual flow which soaks >5 sanitary products per day or requires product change during the night, passage of large blood clots, or failure to respond to conventional therapies. A detailed personal and family history of other bleeding symptoms should also be obtained. Iron deficiency with and without anemia is commonly found in young women with HMB. Therefore, it is important to obtain measures of hemoglobin and ferritin levels when evaluating these patients. Iron supplementation is often a key component of management in the adolescent with heavy menses and is still needed in those who have received packed red cell transfusions as a result of severe anemia. Strategies for decreasing menstrual blood flow are similar for adults and adolescents with heavy menses, with combined hormonal contraceptives recommended as first-line therapy. However, there are adolescent-specific considerations for many of these agents, and they must be incorporated into shared decision-making when selecting the most appropriate treatment.

scholarly journals Role of Sphatik bhasma as haemostatic drug in the Management of Rakta Pradar W.R.T Heavy Menstrual Bleeding

2021 ◽  
Vol 12 (2) ◽  
pp. 289-291
Author(s):  
Deepali Agrwal ◽  
Rajshree Ambhore
Keyword(s):  
Heavy Menstrual Bleeding ◽  
Menstrual Bleeding ◽  
Aluminium Sulphate ◽  
Potassium Alum ◽  
Classical Text ◽  
Before And After ◽  
Abnormal Bleeding ◽  
Common Problems ◽  
Sleeping Habits

Heavy menstrual bleeding or abnormal bleeding is most common problems in females in present era due to improper diet habits, sleeping habits due to increasing degrees of civilisation. There are various treatment on heavy menstrual flow like hormonal replacement therapy where there is hormonal imbalancement, Anti fibrinolytics drugs in dysfunctional uterine bleeding available today. According to Ayurveda it can be correlated with Raktapradar. Various drugs are suggested in raktapradar in classical text. In this study efficacy of Sphatik bhasma (potassium aluminium sulphate also known as potassium alum or potashalum, has a molecular formulae of K2(SO4).Al2(SO4)3.24H2O) as haemostatic drug is observed through clinical trial. The clinical study was conducted on 15 patients having heavy menstrual bleeding. Interventional drug Sphatik Bhasma with pakwa kadali phala (banana or Musa paradisiaca) is administered for 3 days. The clinical assessment was done on the basis of grading criteria of Rakta Pradar like amount and duration of bleeding, pain, burning sensation and weakness and were assessed on mean scores before and after treatment and analysed. The results were statistically and clinically highly significant in Raktapradar.

Sign in / Sign up

Export Citation Format

Share Document